Minimally Invasive Biopsy Technologies Market Demand, Size, Share, Scope & Forecast To 2027: Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Etc
Research Reports
Jan 15, 2021
Minimally Invasive Biopsy Technologies Market is projected to reach USD 3.98 billion in 2027. The market is expected to be driven due to a higher proliferation of the minimally invasive surgical procedures in biopsy testing and an extensive rise in the rate of breast and lung cancers globally. Around 66% of the total initial breast biopsies performed in North America are minimally invasive breast biopsies (MIBB).
Global Minimally Invasive Biopsy Technologies Market research report offers a panoramic view of the Minimally Invasive Biopsy Technologies market, regulatory framework, and macro- and micro-economic factors that influence the growth of the industry. The report strives to offer authentic information about the Minimally Invasive Biopsy Technologies market size, share, product portfolio, revenue estimations, and growth rate.
Growing demand for minimally invasive procedures in biopsy owing to its higher convenience is driving the demand for the market.
Get a sample of the report @ https://www.emergenresearch.com/request-sample-form/75
The report has been formulated through extensive primary and secondary research along with verified and reliable data obtained from industry experts and professionals. The study offers a clear understanding of the current market scenario owing to the COVID-19 pandemic and offers a comprehensive analysis of the current and future impact of the pandemic on the overall market landscape
Top Companies Operating in the Minimally Invasive Biopsy Technologies Market and Profiled in the Report are:
Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies, and Owlstone Medical Ltd., among others.
The report projects the market is anticipated to grow at a significant rate owing to raid advancements and technological developments in the sector. The report offers strategic recommendations to the businesses and investors to capitalize on the lucrative growth opportunities.
The Asia Pacific region, due to its immense rise in the breast & lung cancers & rising usage of the MIB technologies, is expected to accelerate with the fastest growth rate of 20.1% during the projected period 2020 to 2027.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market
Global Minimally Invasive Biopsy Technologies Market Segmentation based on Product Type and Application:
- Technology Outlook (Revenue: USD Billion; 2017-2027)
- Liquid Biopsy
- Optical Biopsy
- Brush Biopsy
- Pigmented Lesion Assays
- Breath Biopsy
- Brush Biopsy
- Others
- Therapeutic Application Outlook (Revenue: USD Billion; 2017-2027)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Blood Cancer
- Non-oncology Applications
- End-Use Verticals Outlook (Revenue: USD Billion; 2017-2027)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Others
The latest report on the global Minimally Invasive Biopsy Technologies market offers strategic insights into the market landscape to stakeholders, investors, and business owners to help them make efficient and lucrative business decisions based on key statistical data and facts. The report aims to offers a thorough outlook of the Minimally Invasive Biopsy Technologies market based on various key elements, such as market drivers, limitations, threats, restraining factors, and growth prospects.
Minimally Invasive Biopsy Technologies Market Segmentation by Regions:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Minimally Invasive Biopsy Technologies Market Segmentation & Impact Analysis
4.1. Minimally Invasive Biopsy Technologies Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing proliferation of the minimally invasive surgical procedure
4.2.2.2. Extensive rise in the cancers & biopsy testing
4.2.2.3. Minimum hospitalization for biopsy testing
4.2.3. Market restraints analysis
4.2.3.1. Unavailability of the skilled professional
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Minimally Invasive Biopsy Technologies Market By Technology Insights & Trends, Revenue (USD Billion)
5.1. Technology Dynamics & Market Share, 2019 & 2027
5.1.1. Liquid Biopsy
5.1.2. Optical Biopsy
5.1.3. Brush Biopsy
5.1.4. Pigmented Lesion Assays
5.1.5. Breath Biopsy
5.1.6. Brush Biopsy
5.1.7. Others
To Be Continued…!
Request customization of the report @ https://www.emergenresearch.com/request-for-customization-form/75
Thank you for reading our report. For further queries regarding the report or customization options, please connect with us. Our team will ensure you get a report well-suited to your needs.
Take a Look at our Related Reports:
Industrial Microbiology Market To Be Worth USD 17.71 Billion by 2027| Emergen Research
Surgical Instrument Tracking Systems Market To Reach USD 431.6 Million by 2027| Emergen Research
Medical Lighting Technologies Market Size To Be Worth USD 2.99 Billion by 2027 | Emergen Research
Smart Irrigation Controllers Market To Be Worth USD 732.7 Million by 2027 Growing at a CAGR of 14.9% | Emergen Research
Soldier System Market to Reach USD 15.19 Billion By 2027 Growing at a CAGR of 4.8% | Emergen Research
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English
YOU MAY ALSO LIKE
PW Consulting Releases Comprehensive Market Research on…
Minimally Invasive Biopsy Technologies Market is projected to reach USD 3.98 billion in 2027. The market is expected to be driven due to a higher…
read more